Reducing pain and repairing tissue are not the same clinical goal.

Summary

The post distinguishes between reducing pain symptoms and promoting structural tissue repair. Steroid injections can provide value when active inflammation drives symptoms, targeting the immediate source of pain. In contrast, regenerative treatments such as prolotherapy and platelet-rich plasma (PRP) aim to support a healing response in weakened or injured connective tissue. Clarifying whether the primary clinical objective is short-term symptom reduction or structural tissue restoration helps guide the selection of appropriate care options.

Conditions and treatments discussed

• Steroid Injections. Steroid injections can reduce symptoms when inflammation drives the underlying pain.
• Prolotherapy. Prolotherapy is a regenerative treatment intended to support healing in weakened or injured connective tissue.
• Platelet-Rich Plasma (PRP). PRP is a regenerative option designed to encourage a restorative response in damaged tissue.

What this shows about Manhattan Pain Medicine

In this post, Manhattan Pain Medicine illustrates the principle of identifying the driver of pain rather than treating every symptom with the same approach. When inflammation drives pain, steroid injections may offer relief, whereas regenerative options such as prolotherapy or platelet-rich plasma (PRP) target tissue repair in weakened connective structures. The post reflects the practice's emphasis on patient education by clarifying the distinction between temporary symptom suppression and structural healing. Understanding these underlying mechanisms allows clinicians to tailor treatment to the exact tissue problem.